Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
Showing 1,501 - 1,520 results of 13,459 for search '(( significant ((side decrease) OR (greater decrease)) ) OR ( significantly increased decrease ))', query time: 0.45s Refine Results
  1. 1501
    Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020.

    Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1502
    Effects of finerenone on the UACR in all patients.

    Effects of finerenone on the UACR in all patients. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1503
    Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time.

    Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1504
    Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients.

    Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1505
    Changes in the UACR and urinary β2-MG levels compared with baseline values over time.

    Changes in the UACR and urinary β2-MG levels compared with baseline values over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1506
    Changes in the eGFRs and serum potassium levels compared with baseline values in all patients over time.

    Changes in the eGFRs and serum potassium levels compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1507
    Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups.

    Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1508
    Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time.

    Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1509
    Changes in inflammatory cytokine levels compared with baseline values in all patients over time.

    Changes in inflammatory cytokine levels compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1510
    Effects of finerenone on the urinary β2-MG levels in all patients.

    Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1511
    S1 Data -

    S1 Data - by Taher Mohammadizad (19786989)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1512
    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B).

    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1513
    Fig 3 -

    Fig 3 - by Aihong Zheng (20571034)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1514
    Complication subgroup analysis of the RAAS system in T2DM patients.

    Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1515
    Flow diagram of patient selection and subgroup classification.

    Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1516
    Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients.

    Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1517
    The values of angiotensin II

    The values of angiotensin II by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1518
    Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC.

    Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC. by Aihong Zheng (20571034)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1519
    S1 Fig -

    S1 Fig - by Aihong Zheng (20571034)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1520
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: